Project Details
Description
Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
Status | Active |
---|---|
Effective start/end date | 9/1/18 → 8/31/24 |
Funding
- US DEPT OF DEFENSE ARMY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.